Today: Nov 13, 2024

AbbVie stocks tumble after schizophrenia drug disappoints

AbbVie stocks tumble after schizophrenia drug disappoints
November 11, 2024



AbbVie stocks tumble after schizophrenia drug disappoints  Monetary TimesAbbVie Inventory Tumbles on Failed Schizophrenia Drug Research. Bristol Myers Jumps.  Barron’sBristol Soars 11% As Traders Query AbbVie’s Expensive ‘Mistake’  Investor’s Industry DailyAbbVie Inventory Sinks After Schizophrenia Drug Trials Disappoint  InvestopediaAbbVie Tumbles After New Schizophrenia Drug Fails in Two Trials  Bloomberg

OpenAI
Author: OpenAI

Don't Miss

A scrap of information on Amgen’s weight problems drug candidate wipes out  billion in marketplace price

A scrap of information on Amgen’s weight problems drug candidate wipes out $12 billion in marketplace price

On Tuesday, a tiny shred of information on Amgen’s lead weight problems
SoftBank-backed Swiggy’s stocks jump over 9% on India marketplace debut after stellar IPO

SoftBank-backed Swiggy’s stocks jump over 9% on India marketplace debut after stellar IPO

Swiggy supply workforce acquire after making an attempt Guinness International report name